Content about Uterine fibroids

March 12, 2012
Watson starts phase-3 trial of Esmya

Drug maker Watson Pharmaceuticals has started a late-stage trial of a drug made to treat benign tumors of the uterus, the company said Monday.

December 16, 2010
Watson, Richter enter licensing agreement for Esmya

A subsidiary of Watson Pharmaceuticals has entered a licensing agreement with a subsidiary of Hungarian drug maker Richter to develop and market a drug for uterine fibroids, the two companies said Thursday.

June 15, 2010
Abbott, Neurocrine Biosciences to commercialize elagolix

Two drug makers will work together to develop a drug for the treatment of endometriosis,...

© 2013 Drug Store News. All Rights Reserved.